Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,71 HKD | +1,21% | +5,01% | -7,58% |
14:06 | Curator van CSPC Pharmaceutical koopt meer aandelen terug | MT |
30/05 | CSPC Pharmaceutical koopt 3 miljoen aandelen terug | MT |
Vakgebied
- geneesmiddelen (78,7%): innovatieve geneesmiddelen (62,5% van de verkoop) en gewone generieke geneesmiddelen (37,5%);
- vitamine C (10,1%)
- antibiotica (6,2%);
- overige (5%): inclusief watervrije en ruwe cafeïne.
De netto-omzet is geografisch als volgt verdeeld: China (82,8%), Azië (7,2%), Europa (4,6%), Noord- en Zuid-Amerika (4,4%) en overige (1%).
Aantal werknemers: 23 500
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Finished Drugs
81,5
%
| 24 520 | 79,3 % | 28 329 | 81,5 % | +15,53% |
Functional Food and Others
6,9
%
| 1 966 | 6,4 % | 2 400 | 6,9 % | +22,06% |
Bulk Products - Vitamin C
6,1
%
| 2 529 | 8,2 % | 2 132 | 6,1 % | -15,70% |
Bulk Products - Antibiotics
5,4
%
| 1 922 | 6,2 % | 1 892 | 5,4 % | -1,57% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
86,4
%
| 26 139 | 84,5 % | 30 038 | 86,4 % | +14,91% |
Other Asian Regions
5,0
%
| 1 736 | 5,6 % | 1 749 | 5,0 % | +0,77% |
Europe
4,1
%
| 1 268 | 4,1 % | 1 411 | 4,1 % | +11,27% |
North America
2,8
%
| - | - | 974 | 2,8 % | - |
Others
1,7
%
| 284 | 0,9 % | 580 | 1,7 % | +104,23% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cui Long Zhang
CEO | Chief Executive Officer | 55 | 01-01-96 |
Dong Chen Cai
CHM | Chairman | 70 | 01-01-98 |
Hao Jiang
BRD | Director/Board Member | 41 | 01-08-20 |
Zhen Guo Wang
BRD | Director/Board Member | 54 | 20-01-12 |
Huai Yu Wang
BRD | Director/Board Member | 61 | 01-01-10 |
Wei Dong Pan
BRD | Director/Board Member | 55 | 01-01-06 |
Jin Xu Wang
PRN | Corporate Officer/Principal | 53 | 10-06-13 |
Tai On Lo
SEC | Corporate Secretary | 69 | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dong Chen Cai
CHM | Chairman | 70 | 01-01-98 |
Wei Dong Pan
BRD | Director/Board Member | 55 | 01-01-06 |
Bo Wang
BRD | Director/Board Member | 64 | 21-12-12 |
Cheuk Kin Law
BRD | Director/Board Member | 61 | 08-03-21 |
Zhen Guo Wang
BRD | Director/Board Member | 54 | 20-01-12 |
Chun Kwok Au
BRD | Director/Board Member | 51 | 27-01-21 |
Jin Xu Wang
PRN | Corporate Officer/Principal | 53 | 10-06-13 |
Chun Lei Li
BRD | Director/Board Member | - | 12-12-17 |
Cui Long Zhang
CEO | Chief Executive Officer | 55 | 01-01-96 |
Hao Jiang
BRD | Director/Board Member | 41 | 01-08-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 11 896 091 732 | 8 344 572 069 ( 70,15 %) | 0 | 70,15 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
157 520 510 | 100.00% | 745 456 362 $ | |
51 241 785 | 46.32% | 48 809 850 $ |
Bedrijfsgegevens
CSPC Pharmaceutical Group Ltd.
No. 226 Huanghe Street
050035, Shijiazhuang
+86 31 1870 37015
http://www.cspc.com.hkSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,58% | 10,04 mld. | |
+41,99% | 739 mld. | |
+32,34% | 598 mld. | |
-5,96% | 353 mld. | |
+17,39% | 318 mld. | |
+3,26% | 285 mld. | |
+16,47% | 240 mld. | |
+9,26% | 210 mld. | |
-5,07% | 206 mld. | |
+5,85% | 164 mld. |
- Beurs
- Aandelen
- Koers 1093
- Onderneming CSPC Pharmaceutical Group Ltd.